Dr. Pei-Yong Shi was referenced in the magazine’s coverage about the omicron variant.

Dr. Pei-Yong Shi discussed the new variant on Houston Matters, a radio program on Houston Public Media.

The University of Texas Medical Branch in Galveston will not enforce a vaccine requirement for its students and workforce, due to take effect Dec. 6, after a U.S. district judge granted a temporary injunction against a federal vaccine mandate for health care workers, UTMB announced Wednesday.

The speedy detection and the rapid response of global health authorities shows how the world’s fight against COVID-19 has evolved. Scientists are now focused on finding new variants. In the case of Omicron, one was beginning to spread in South Africa, a nation with the resources to identify it—and the political will to announce it to the world. Experiments using infectious virus or that tease out the effect of individual mutations on its behavior will take more time, but research that looks at the interactions between Omicron’s mutant spike and antibodies should yield some answers on the immune evasion question in as little as a week, said Vineet Menachery, a virologist at the University of Texas Medical Branch.

Omicron, the newest coronavirus variant, is also the quickest to be labeled a "variant of concern" by the World Health Organization because of its seemingly fast spread in South Africa and its many troubling mutations. It carries a mutation called N501Y, which gave both Alpha and Gamma their increased transmissibility. Just last week, Scott Weaver of the University of Texas Medical Branch and colleagues reported in the journal Nature that this particular mutation made the virus better at replicating in the upper airway—think in the nose and throat—and likely makes it more likely to spread when people breathe, sneeze and cough.

World renowned for his work in Ebola treatments, Gary Kobinger is now tasked with moving the Galveston National Lab into the post-COVID world of viral research.

Dr. Gulshan Sharma, the chief medical officer at the University of Texas Medical Branch, said the county is in a much better place than it was exactly a year ago, when cases were on the rise, vaccines were yet to be approved and treatments, like monoclonal antibodies, weren’t yet widely available. “I’m cautiously optimistic,” Sharma said.

Most employees at the University of Texas Medical Branch don’t live on the island either, said Vivian Kardow, vice president of human resources and chief human resources officer. The medical branch imports 73 percent, 7,411, of its 10,122 Galveston campus employees from the mainland. Across all its campuses, the medical branch employs 15,361 people. The high cost of housing makes recruiting a challenge, she said.

Current and former CDC officials spoke of a man with a unique ability to solve medical mysteries by studying tissues for the signatures of the infectious agent at play. “He really was kind of the secret weapon for a lot of what was done at CDC on emerging diseases,” said James LeDuc, who recently retired as director of the Galveston National Laboratory at the University of Texas Medical Branch. Tom Ksiazek, a former CDC colleague and current professor of microbiology at UTMB’s Galveston National Laboratory, said Zaki pioneered the use of immunohistochemistry to identify foreign proteins in samples sent to the CDC, to help determine the underlying pathogens for a particular outbreak and understand the disease they caused. According to Ksiazek, Zaki’s reputation for cracking hard cases meant that the CDC has been enlisted to help solve outbreaks that other laboratories couldn’t.